(loteprednol etabonate ophthalmic ointment 0.5%)
First Monotherapy Steroid Ointment in the U.S. Market in More Than Two Decades
MADISON, NJ—Bausch + Lomb, the global eye health company, has added a new product to its signature loteprednol etabonate line: LOTEMAX® Ointment.
LOTEMAX Ointment is indicated to treat post-operative inflammation and pain following ocular surgery. LOTEMAX Ointment is the first preservative-free topical ophthalmic steroid formulation in the U.S. It is also the first monotherapy steroid ointment brought to the U.S. market in over 20 years.
“Loteprednol is a molecule I’ve grown to trust because of its effective anti-inflammatory activity,” said Terry Kim, M.D., of Duke University Eye Center. “A preservative-free steroid is something we have anticipated for some time now. LOTEMAX Ointment offers me one more option to provide to my patients.”
Two four-week clinical safety and efficacy evaluations of LOTEMAX Ointment showed statistically significant resolution of anterior chamber cells and flare vs. vehicle at post-operative day eight. Both clinical trials were Phase 3, randomized, multi-center, double-masked parallel-group comparative evaluations to a vehicle (mineral oil and white petrolatum) for the treatment of inflammation and pain following cataract surgery (N=805 total) with LOTEMAX Ointment.
Bausch + Lomb is currently shipping LOTEMAX Ointment. The product is available only within the United States.
Important Risk Information about LOTEMAX® Ointment
Please click here for full prescribing information(381 KB, PDF)
About Bausch + Lomb
Bausch + Lomb is one of the best-known and most respected healthcare companies in the world. Its core businesses include contact lenses and lens care products, ophthalmic surgical devices and instruments, and ophthalmic pharmaceuticals. Founded in 1853, the company is headquartered in Rochester, N.Y., and employs more than 10,000 people worldwide. Its products are available in more than 100 countries. More information is available at www.bausch.com
The website you are about to visit is not affiliated with Bausch + Lomb Incorporated. Bausch + Lomb is not responsible for the content, format, maintenance, or policies of the website you are about to enter and does not monitor non-affiliated websites for accuracy. Links to non-affiliated websites are provided as a convenience; they do not constitute an endorsement or support of any programs, products, or services associated with the website.